Prescott General Partners LLC Age X Therapeutics, Inc. Transaction History

Prescott General Partners LLC

  • $1.5 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
BUY
$2.49 - $5.5 $461,110 - $1.02 Million
185,185 New
185,185 $554,000

Others Institutions Holding AGE

# of Institutions
1
Shares Held
1K
Call Options Held
0
Put Options Held
0
View Full List

About AgeX Therapeutics, Inc.

AGE Quotes by TradingView
  • Ticker AGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,945,100
  • Description
  • AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...
More about AGE
Track This Portfolio

Track Prescott General Partners LLC Portfolio

Follow Prescott General Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prescott General Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prescott General Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email